Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vitro
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018
Report date:
2018

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
Deviations:
not specified
GLP compliance:
yes
Type of study:
activation of keratinocytes

Test material

Constituent 1
Reference substance name:
Rape oil, polymer with tung oil
EC Number:
606-051-0
Cas Number:
185323-46-0
IUPAC Name:
Rape oil, polymer with tung oil

In vitro test system

Details on the study design:
KeratinoSens cells were plated on 96-well tissue culture treated black walled clear bottom polystyrene plates, 125µL per well. The cells were left for 24 h to adhere and the media was replaced with a low serum medium prior to dosing with the test compound at a range of 12 concentrations (see Assay Summary for details). Each compound is dosed on two separate plates, one to determine luminsence (Keap1-Nrf2-ARE pathway) and a second to determine cytotoxicity (MTT cell viability assay). Following an incubation period of 48 h, the cells were either lysed and assessed for the luciferase reporter gene expression using a luminescent assay (Luciferase Assay Kit, Promega) and the BioTek luminometer or loaded with MTT [yellow; 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide]. After 4 hour incubation the resulting formazan from the MTT cell viability assay was solubilised in a 10% SDS solution. The plates were then scanned at 570nm using a SunriseTM microplate absorbance reader (TECAN).

Results and discussion

In vitro / in chemico

Results
Key result
Run / experiment:
mean
Parameter:
other: Calc. EC1.5 (%)
Value:
0.015
Remarks on result:
no indication of skin sensitisation

Any other information on results incl. tables

 

Test Compound Response

Compound Id

Calc.EC1.5(%)

 

Flag

Sensitizing

 

Exp. 1

Exp. 2

Exp. 3

Mean±SD

 

Potential

PhytoVie® Defense

0.0149

>0.02

>0.02

0.0149

1/3

 

No (-)

Calc. EC1.5 : Effective concentration at 1.5 fold increase.

Flag : The number of experiments showing a sensitizing potential out of the total number of experiments. Yes (+) Compound shows sensitizing potential.

No (-) : Compound does not show sensitizing potential.

No (-) * : Compound shows borderline senstizing potential.

Assay Summary

Incubation time:

48h

Concentrations (%):

0.00001, 0.00002, 0.00004, 0.00008, 0.00016, 0.000315,  0.00063,

 

0.00125, 0.0025, 0.005, 0.01, 0.02

Replicates per concentration:

3

Cell model:

KeratinoSens

Vehicle:

DMSO

MW:

999.99

KeratinoSens vehicle SD:

10% (passed), 16% (passed), 10% (passed)

Certified on:

2018-04-17

Data Summary

 

Calc.IC30(%)

MR (%)

MR(%)

Cell viability (MTT) 1

>0.02

NR

NR

Cell viability (MTT) 2

>0.02

NR

NR

Cell viability (MTT) 3

>0.02

NR

NR

 

Sensitizing Potential

Calc.EC1.5(%)

MR(Imax)

MR(%)

KeratinoSens 1

 

Yes (+)

0.0149

1.58

0.02

KeratinoSens 2

 

No (-)

>0.02

NR

NR

KeratinoSens 3

 

No (-)

>0.02

1.41

0.02

Calc. EC1.5 : Effective concentration at 1.5 fold increase.

Calc. IC30 : Inhibitory concentration at 30% loss of cell viability. MR (Imax ) Maximum fold response of KeratinoSens.

MR    (%)    : Maximum     %     response. 

MR (%) : Maximum fold response concentration.

Yes (+) : Compound shows sensitizing potential.

No (-) : Compound does not show sensitizing potential.

No (-) * : Compound shows borderline senstizing potential. NR No response observed.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Compound does not show sensitizing potential.